Stock data
Passage Bio, Inc. (PASG)
Passage Bio, Inc. (PASG) reported net income of -US$45.52M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$49.30M | -US$45.52M | — |
| 2024 | — | — | -US$70.40M | -US$64.77M | — |
| 2023 | — | — | -US$108.39M | -US$102.06M | — |
| 2022 | — | — | -US$138.39M | -US$136.12M | — |
| 2021 | — | — | -US$185.73M | -US$185.39M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$7.82M | — |
| 2026-03-31 | — | -US$7.56M | — |
| 2025-12-31 | — | -US$12.98M | — |
| 2025-09-30 | — | -US$7.75M | — |
| 2025-06-30 | — | -US$9.38M | — |
| 2025-03-31 | — | -US$15.40M | — |
| 2024-12-31 | — | -US$12.72M | — |
| 2024-09-30 | — | -US$19.34M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.